The first study of its kind has pinpointed optimal thresholds for two noninvasive tests to identify significant fibrosis among patients with nonalcoholic steatohepatitis.
According to a multicenter team of researchers, these levels for the Fibrosis-4 (FIB-4) score and aspartate aminotransferase-to-platelet ratio index (APRI) can be used to identify significant fibrosis with an acceptable level of accuracy.
Elliot Tapper, MD, an assistant professor of medicine at the University of Michigan Medical